DUSP2 and central nervous system cancer: Furthermore, we confirmed the interaction of miR-17-5p with DUSP2 3’UTR which was previously reported to be highly expressed and associated with poor prognosis in gliomas and described as efficiently de-coupling other negative regulators of the MAPK pathway [61, 83].